Opportunity Information: Apply for PAR 25 144

The National Institutes of Health (NIH) funding opportunity "Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)" (PAR-25-144) supports research that helps close the gap between what is known to improve health and what is actually delivered in real-world settings. The central goal is to fund studies that identify, develop, and/or rigorously test strategies that overcome common real-world barriers to putting evidence-based interventions into routine practice. In this context, "evidence-based interventions" is used broadly and can include clinical treatments, preventive services, behavioral interventions, public health programs, tools and technologies, practice guidelines, and even policies. The work is focused less on discovering new interventions and more on figuring out how to get proven interventions adopted and used effectively, consistently, and sustainably across different systems and communities.

A major emphasis of the NOFO is understanding and improving the processes that determine whether evidence-based interventions are adopted, adapted appropriately to local contexts, integrated into workflows, maintained over time, expanded to more sites (scale-up), and spread across organizations or regions. The opportunity recognizes that even strong interventions can fail when implementation is poorly supported or when they do not fit local constraints such as staffing, financing, leadership, infrastructure, culture, or patient needs. Projects under this NOFO typically examine implementation strategies (the methods used to promote uptake, such as training models, audit and feedback, facilitation, policy changes, incentive structures, clinical decision support, workflow redesign, or community-engaged approaches) and evaluate how well those strategies perform in real settings.

The NOFO explicitly encourages studies that promote equitable dissemination and implementation, meaning it values research designed to ensure that evidence-based interventions reach and benefit populations that have been historically underrepresented or underserved. This includes addressing structural and contextual factors that contribute to disparities in access, quality, and outcomes. In practice, this could involve tailoring implementation strategies to improve reach, acceptability, and effectiveness in specific communities; partnering with community-based organizations; addressing language and cultural barriers; or testing approaches that reduce inequities created by geography, resource constraints, discrimination, or gaps in healthcare delivery.

Another key component is "de-implementation," which focuses on reducing or stopping the use of practices that are ineffective, unproven, low-value, or harmful. The NOFO highlights that improving health systems is not only about increasing adoption of good practices, but also about understanding how and why outdated or harmful practices persist and what strategies successfully remove them. De-implementation research can include identifying drivers of overuse, measuring harms and opportunity costs, and testing approaches to change clinician behavior, organizational norms, reimbursement incentives, or patient expectations.

The NOFO also welcomes proposals that advance dissemination and implementation research methods and measures. That includes improving the tools researchers and practitioners use to assess implementation outcomes (for example, adoption, fidelity, feasibility, acceptability, penetration, sustainability, cost, and equity impacts), developing stronger study designs for real-world implementation questions, and refining frameworks and analytic approaches for complex, multi-level health systems. Method-focused projects are relevant when they meaningfully strengthen how implementation research is conducted and interpreted, especially across diverse settings.

In addition, the NOFO notes continued relevance of research on re-implementation, especially when evidence-based health services are disrupted by disasters such as pandemics or climate-related events. This reflects a practical concern: services can be interrupted due to workforce shortages, supply chain breakdowns, facility closures, or shifting priorities, and systems then need tested strategies to restore and stabilize effective care. Proposed studies can examine how to resume delivery, rebuild implementation supports, and strengthen resilience so that evidence-based services are less vulnerable to future disruptions.

This is an R01 mechanism, meaning it is intended for well-developed research projects that can support substantial, multi-year investigations. Clinical trials are optional, so applicants may propose trials when appropriate, but they are not required. All projects must fit within the mission and scientific scope of one of the participating NIH Institutes and Centers associated with the announcement, so applicants should align their topic area, setting, and outcomes with the priorities of the relevant NIH component.

Eligibility is broad and includes many types of U.S. and non-U.S. organizations. Eligible applicants listed include state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities and Indian housing authorities; nonprofits with or without 501(c)(3) status; for-profit organizations (other than small businesses) as well as small businesses; and other entities. The NOFO also highlights additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and non-domestic (non-U.S.) entities (foreign organizations). This breadth supports the real-world, cross-sector nature of dissemination and implementation research, which often involves partnerships among healthcare systems, public health agencies, community organizations, schools, and policy stakeholders.

Key administrative details from the source information include that the agency is the NIH, the opportunity category is discretionary, and the funding instrument is a grant. The opportunity was created on 2024-10-29 and lists an original closing date of 2028-01-07, suggesting a multi-year posting with multiple due dates typical of NIH program announcements. The funding activity categories span education, environment, food and nutrition, health, and income security and social services, reflecting the wide range of settings where implementation barriers and solutions may be studied. The opportunity also lists multiple CFDA numbers (now often referred to under assistance listings), indicating participation across numerous NIH components and program areas.

Overall, PAR-25-144 is aimed at researchers and implementation partners who want to generate practical, generalizable evidence about how to increase the real-world use, quality, and durability of proven health interventions, while also reducing inequities, eliminating low-value care, improving implementation research methods, and strengthening the ability of health services to recover and function during and after disruptive events.

  • The National Institutes of Health in the education, environment, food and nutrition, health, income security and social services sector is offering a public funding opportunity titled "Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.113, 93.121, 93.172, 93.213, 93.233, 93.242, 93.273, 93.279, 93.307, 93.310, 93.361, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.865, 93.866, 93.867.
  • This funding opportunity was created on 2024-10-29.
  • Applicants must submit their applications by 2028-01-07.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PAR 25 144

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

FAQs: NIH Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) (PAR-25-144)

1) What is PAR-25-144 trying to fund?

PAR-25-144 funds dissemination and implementation (D&I) research that helps close the gap between what research shows works to improve health and what actually gets delivered in real-world settings. The focus is on practical, real-world strategies that increase the adoption, effective use, and long-term maintenance of evidence-based interventions.

2) What is the main goal of this funding opportunity?

The central goal is to support studies that identify, develop, and/or rigorously test implementation strategies that overcome common barriers to putting evidence-based interventions into routine practice across systems and communities.

3) Does this opportunity fund discovery of new health interventions?

The emphasis is less on discovering new interventions and more on figuring out how to get proven interventions adopted and used effectively, consistently, and sustainably in real-world contexts.

4) What counts as an "evidence-based intervention" under this NOFO?

The term is used broadly and can include clinical treatments, preventive services, behavioral interventions, public health programs, tools and technologies, practice guidelines, and policies.

5) What kinds of real-world barriers are projects expected to address?

Projects are expected to address barriers that commonly limit successful implementation in practice, such as staffing, financing, leadership, infrastructure, organizational culture, workflow constraints, and patient needs, among other local constraints.

6) What topics are emphasized within dissemination and implementation research for this NOFO?

A major emphasis is on understanding and improving the processes that influence whether evidence-based interventions are adopted, appropriately adapted to local contexts, integrated into workflows, maintained over time (sustainability), expanded to more sites (scale-up), and spread across organizations or regions (spread).

7) What are "implementation strategies" in the context of this opportunity?

Implementation strategies are the methods used to promote uptake of evidence-based interventions in real settings. Examples mentioned include training models, audit and feedback, facilitation, policy changes, incentive structures, clinical decision support, workflow redesign, and community-engaged approaches.

8) Are projects expected to evaluate implementation strategies in real settings?

Yes. Projects under this NOFO typically examine implementation strategies and evaluate how well those strategies perform in real-world settings.

9) How does the NOFO define or prioritize equity?

The NOFO explicitly encourages equitable dissemination and implementation research, valuing studies designed to ensure evidence-based interventions reach and benefit populations that have been historically underrepresented or underserved. This includes addressing structural and contextual factors that contribute to disparities in access, quality, and outcomes.

10) What are examples of equity-focused approaches that fit this NOFO?

Examples described include tailoring implementation strategies to improve reach, acceptability, and effectiveness in specific communities; partnering with community-based organizations; addressing language and cultural barriers; and testing approaches that reduce inequities tied to geography, resource constraints, discrimination, or gaps in healthcare delivery.

11) What is "de-implementation," and is it supported here?

De-implementation is the process of reducing or stopping the use of practices that are ineffective, unproven, low-value, or harmful. The NOFO highlights de-implementation as a key component and welcomes research that identifies why outdated or harmful practices persist and tests strategies to reduce or remove them.

12) What kinds of questions could de-implementation research address under this NOFO?

The NOFO notes examples such as identifying drivers of overuse, measuring harms and opportunity costs, and testing approaches to change clinician behavior, organizational norms, reimbursement incentives, or patient expectations.

13) Does PAR-25-144 support methods and measurement development in D&I research?

Yes. The NOFO welcomes proposals that advance D&I research methods and measures, including improving tools used to assess implementation outcomes and strengthening study designs, frameworks, and analytic approaches for complex, multi-level health systems.

14) What implementation outcomes are specifically mentioned as measurement targets?

The NOFO gives examples of implementation outcomes such as adoption, fidelity, feasibility, acceptability, penetration, sustainability, cost, and equity impacts.

15) What is "re-implementation," and why is it relevant to this opportunity?

Re-implementation refers to restoring evidence-based health services after they have been disrupted. The NOFO notes continued relevance of re-implementation research, especially following disasters such as pandemics or climate-related events that can interrupt services.

16) What kinds of disruptions does the NOFO mention that can affect health service delivery?

The NOFO mentions disruptions such as workforce shortages, supply chain breakdowns, facility closures, and shifting priorities, which can interrupt delivery of evidence-based services.

17) What types of re-implementation questions could be studied under PAR-25-144?

Examples described include studying how to resume delivery of effective care, rebuild implementation supports, and strengthen system resilience so evidence-based services are less vulnerable to future disruptions.

18) What funding mechanism is used for PAR-25-144?

This opportunity uses the NIH R01 mechanism, which is intended for well-developed research projects that can support substantial, multi-year investigations.

19) Are clinical trials required?

No. Clinical trials are optional. Applicants may propose clinical trials when appropriate, but they are not required.

20) Do projects need to align with specific NIH Institutes and Centers?

Yes. Projects must fit within the mission and scientific scope of one of the participating NIH Institutes and Centers associated with the announcement. Applicants should align the topic, setting, and outcomes with the priorities of the relevant NIH component.

21) Who is eligible to apply?

Eligibility is broad and includes many U.S. and non-U.S. organizations. Eligible applicants listed include state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities and Indian housing authorities; nonprofits with or without 501(c)(3) status; for-profit organizations (other than small businesses) and small businesses; and other entities.

22) Are specific institution types and community organizations highlighted as eligible?

Yes. The NOFO highlights additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, AANAPISIs, Hispanic-serving Institutions, HBCUs, TCCUs, faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and non-domestic (non-U.S.) entities (foreign organizations).

23) What kinds of partnerships does this opportunity appear to support?

Because D&I research is often cross-sector and real-world, the NOFO’s broad eligibility supports partnerships among healthcare systems, public health agencies, community organizations, schools, and policy stakeholders.

24) What is the funding agency and award type?

The agency is the National Institutes of Health (NIH). The opportunity category is discretionary, and the funding instrument is a grant.

25) When was this opportunity created and what closing date is listed?

The opportunity was created on 2024-10-29 and lists an original closing date of 2028-01-07, suggesting a multi-year posting with multiple due dates typical of NIH program announcements.

26) What activity areas does this opportunity touch?

The funding activity categories span education, environment, food and nutrition, health, and income security and social services, reflecting that implementation barriers and solutions can be studied across many settings that influence health.

27) What are CFDA/Assistance Listing numbers doing in the opportunity description?

The opportunity lists multiple CFDA numbers (now often referred to as Assistance Listings), indicating participation across numerous NIH components and program areas.

28) What is the overall takeaway of PAR-25-144?

PAR-25-144 is aimed at generating practical, generalizable evidence about how to increase real-world use, quality, and durability of proven health interventions, while also reducing inequities, eliminating low-value or harmful care through de-implementation, advancing D&I methods and measures, and strengthening health service resilience and recovery after disruptions.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Environment, Food and Nutrition, Health, Income Security and Social Services

Next opportunity: Targeting Inflammasomes in HIV and Substance Use (R21 Clinical Trial Not Allowed)

Previous opportunity: National Animal Disease Preparedness and Response Program Fiscal Year 2025 Tribal Funding Opportunity Announcement

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 25 144

 

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 25 144) also looked into and applied for these:

Funding Opportunity
Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed) Apply for PAR 25 134

Funding Number: PAR 25 134
Agency: National Institutes of Health
Category: Education, Environment, Food and Nutrition, Health, Income Security and Social Services
Funding Amount: $375,000
NIH Research Project Grant (Parent R01 Clinical Trial Required) Apply for PA 25 305

Funding Number: PA 25 305
Agency: National Institutes of Health
Category: Education, Environment, Food and Nutrition, Health, Income Security and Social Services
Funding Amount: Case Dependent
NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) Apply for PA 25 301

Funding Number: PA 25 301
Agency: National Institutes of Health
Category: Education, Environment, Food and Nutrition, Health, Income Security and Social Services
Funding Amount: Case Dependent
NIH Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required) Apply for PA 25 303

Funding Number: PA 25 303
Agency: National Institutes of Health
Category: Education, Environment, Food and Nutrition, Health, Income Security and Social Services
Funding Amount: Case Dependent
Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) Apply for PAR 25 379

Funding Number: PAR 25 379
Agency: National Institutes of Health
Category: Education, Environment, Food and Nutrition, Health, Income Security and Social Services
Funding Amount: Case Dependent
Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed) Apply for PAR 25 414

Funding Number: PAR 25 414
Agency: National Institutes of Health
Category: Education, Environment, Food and Nutrition, Health, Income Security and Social Services
Funding Amount: $100,000
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30) Apply for PA 25 425

Funding Number: PA 25 425
Agency: National Institutes of Health
Category: Education, Environment, Food and Nutrition, Health, Income Security and Social Services
Funding Amount: Case Dependent
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32) Apply for PA 25 423

Funding Number: PA 25 423
Agency: National Institutes of Health
Category: Education, Environment, Food and Nutrition, Health, Income Security and Social Services
Funding Amount: Case Dependent
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30) Apply for PA 25 426

Funding Number: PA 25 426
Agency: National Institutes of Health
Category: Education, Environment, Food and Nutrition, Health, Income Security and Social Services
Funding Amount: Case Dependent
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31) Apply for PA 25 422

Funding Number: PA 25 422
Agency: National Institutes of Health
Category: Education, Environment, Food and Nutrition, Health, Income Security and Social Services
Funding Amount: Case Dependent
Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed) Apply for PAR 25 415

Funding Number: PAR 25 415
Agency: National Institutes of Health
Category: Education, Environment, Food and Nutrition, Health, Income Security and Social Services
Funding Amount: $125,000
Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed) Apply for PAR 25 322

Funding Number: PAR 25 322
Agency: National Institutes of Health
Category: Education, Environment, Food and Nutrition, Health, Income Security and Social Services
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 25 144", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: